search
Back to results

Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest

Primary Purpose

Out-of-hospital Cardiac Arrest

Status
Completed
Phase
Phase 4
Locations
Slovenia
Study Type
Interventional
Intervention
Amoxicillin-Clavulanic acid
Sponsored by
University Medical Centre Ljubljana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Out-of-hospital Cardiac Arrest focused on measuring Out-of-hospital cardiac arrest, Prophylactic antibiotics

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Female and male over 18 years old
  • Comatose survivors of out-of-hospital cardiac arrest treated in intensive care unit with therapeutic hypothermia

Exclusion Criteria:

  • Suspected or confirmed pregnancy
  • Allergy to amoxicillin-clavulanic acid
  • Tracheobronchial aspiration
  • Antibiotic therapy before cardiac arrest
  • Need of antibiotics due to other causes
  • Candidates for immediate veno-arterial extracorporeal membrane oxygenation (VA ECMO)
  • Patients in whom no active treatment was decided on admission

Sites / Locations

  • University Medical Centre Ljubljana

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Prophylactic antibiotic

Clinically-driven antibiotics

Arm Description

Amoxicillin-Clavulanic acid 1.2g every 8h

Administration of antibiotics in clinically-driven group was at the discretion of attending intensivist. Selection of antibiotic in clinically-driven group was empirical or based on the results of bacterial cultures if already available.

Outcomes

Primary Outcome Measures

Value of C-reactive protein (CRP) at day three
Expressed in milligram/litre (normal <5 mg/L)

Secondary Outcome Measures

Severity of systemic inflammatory response estimated by peak white blood cell count (WBC)
Expressed in number of white blood cells x 109 per litre (L)
Severity of systemic inflammatory response estimated by peak value of procalcitonin (PCT)
Expressed in microgram/litre (normal <0.5 microgram/L)
Severity of systemic inflammatory response estimated by peak value of neutrophil Cluster of differentiation 64 (CD 64)
Neutrophil CD 64 expression was used as an index of sepsis with >1.2 indicating greater likelihood of sepsis
Appearance of pneumonia on chest X ray
Incidence of positive blind mini bronchoalveolar lavage (Mini-BAL) on day 3
Incidence of positive hemocultures
Duration of tracheal intubation
Duration of intubation was expressed as days of intubation started with admission until the extubation. Because this is being done in intensive care unite, the time frame is duration of ICU stay
Duration of mechanical ventilation
Duration of mechanical ventilation was expressed as days the patient needed the mechanical support for breathing regardless of mode of support
ICU stay
Survival with good neurological outcome
Good neurological outcome was characterised using cerebral performance category (CPC) with 1-2 indicating good neurological recovery.

Full Information

First Posted
June 30, 2016
Last Updated
September 8, 2016
Sponsor
University Medical Centre Ljubljana
search

1. Study Identification

Unique Protocol Identification Number
NCT02899507
Brief Title
Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest
Official Title
Prophylactic Versus Clinically-driven Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
September 2013 (undefined)
Primary Completion Date
March 2015 (Actual)
Study Completion Date
April 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Medical Centre Ljubljana

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether there is potential benefits of prophylactic antibiotic treatment in comatose survivors of out-of-hospital cardiac arrest (OHCA) treated in intensive care unit with therapeutic hypothermia.
Detailed Description
Postresuscitation management of comatose survivors of out-of-hospital cardiac arrest (OHCA) significantly improved and "bundle of care" including therapeutic hypothermia, immediate coronary angiography, percutaneous coronary intervention (PCI) and contemporary intensive care nowadays leads to survival with good neurological recovery. Benefit of prophylactic antibiotics, which may suppress development of postresuscitation infection and especially early onset pneumonia and thereby decrease the severity of postresuscitation systemic inflammatory response, is controversial. Because of these uncertainties, the investigators performed a single-center randomized clinical trial comparing prophylactic versus clinically-driven administration of antibiotics in comatose survivors of OHCA. The investigators hypothesized that prophylactic antibiotics may decrease the severity of postresuscitation systemic inflammatory response by reducing the incidence of postresuscitation infection and especially pneumonia which was further addressed by repeat microbiological sampling.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Out-of-hospital Cardiac Arrest
Keywords
Out-of-hospital cardiac arrest, Prophylactic antibiotics

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Prophylactic antibiotic
Arm Type
Experimental
Arm Description
Amoxicillin-Clavulanic acid 1.2g every 8h
Arm Title
Clinically-driven antibiotics
Arm Type
No Intervention
Arm Description
Administration of antibiotics in clinically-driven group was at the discretion of attending intensivist. Selection of antibiotic in clinically-driven group was empirical or based on the results of bacterial cultures if already available.
Intervention Type
Drug
Intervention Name(s)
Amoxicillin-Clavulanic acid
Other Intervention Name(s)
Amoksiklav, Augmentin
Intervention Description
Patients without evidence of tracheobronchial aspiration were randomized to immediate prophylactic Amoxicillin-Clavulanic acid 1,2 gr/8h
Primary Outcome Measure Information:
Title
Value of C-reactive protein (CRP) at day three
Description
Expressed in milligram/litre (normal <5 mg/L)
Time Frame
Three days after admission to Intensive care unit (ICU)
Secondary Outcome Measure Information:
Title
Severity of systemic inflammatory response estimated by peak white blood cell count (WBC)
Description
Expressed in number of white blood cells x 109 per litre (L)
Time Frame
First measurement at admission in hospital and afterwards in 24 hours intervals during stay in the intensive care unite (ICU) but not longer then first seven days
Title
Severity of systemic inflammatory response estimated by peak value of procalcitonin (PCT)
Description
Expressed in microgram/litre (normal <0.5 microgram/L)
Time Frame
First measurement at admission in hospital and afterwards in 24 hours intervals during stay in the intensive care unite (ICU) but not longer then first seven days
Title
Severity of systemic inflammatory response estimated by peak value of neutrophil Cluster of differentiation 64 (CD 64)
Description
Neutrophil CD 64 expression was used as an index of sepsis with >1.2 indicating greater likelihood of sepsis
Time Frame
First measurement at admission in hospital and afterwards in 24 hours intervals in the first three days
Title
Appearance of pneumonia on chest X ray
Time Frame
Chest X ray was taken on admission and afterwards on daily basis during the stay in the intensive care unite but not longer than first week
Title
Incidence of positive blind mini bronchoalveolar lavage (Mini-BAL) on day 3
Time Frame
Mini-BAL was performed on the third day after the sudden cardiac arrest
Title
Incidence of positive hemocultures
Time Frame
From the admission until the patient was transferred to the ward. This was always during the ICU stay-one month
Title
Duration of tracheal intubation
Description
Duration of intubation was expressed as days of intubation started with admission until the extubation. Because this is being done in intensive care unite, the time frame is duration of ICU stay
Time Frame
From the day of admission until the extubation. This was always during the ICU stay- one month
Title
Duration of mechanical ventilation
Description
Duration of mechanical ventilation was expressed as days the patient needed the mechanical support for breathing regardless of mode of support
Time Frame
From the admission until spontaneous breathing . This was during ICU stay-one month
Title
ICU stay
Time Frame
From the admission until the patient was transferred to ward, usually less than one month
Title
Survival with good neurological outcome
Description
Good neurological outcome was characterised using cerebral performance category (CPC) with 1-2 indicating good neurological recovery.
Time Frame
Up to six months after the event

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Female and male over 18 years old Comatose survivors of out-of-hospital cardiac arrest treated in intensive care unit with therapeutic hypothermia Exclusion Criteria: Suspected or confirmed pregnancy Allergy to amoxicillin-clavulanic acid Tracheobronchial aspiration Antibiotic therapy before cardiac arrest Need of antibiotics due to other causes Candidates for immediate veno-arterial extracorporeal membrane oxygenation (VA ECMO) Patients in whom no active treatment was decided on admission
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marko Noč, MD, PhD
Organizational Affiliation
University Medical Centre Ljubljana
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Centre Ljubljana
City
Ljubljana
ZIP/Postal Code
1000
Country
Slovenia

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21636202
Citation
Tomte O, Andersen GO, Jacobsen D, Draegni T, Auestad B, Sunde K. Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study. Resuscitation. 2011 Sep;82(9):1186-93. doi: 10.1016/j.resuscitation.2011.05.003. Epub 2011 May 14.
Results Reference
background
PubMed Identifier
21184989
Citation
Stub D, Hengel C, Chan W, Jackson D, Sanders K, Dart AM, Hilton A, Pellegrino V, Shaw JA, Duffy SJ, Bernard S, Kaye DM. Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest. Am J Cardiol. 2011 Feb 15;107(4):522-7. doi: 10.1016/j.amjcard.2010.10.011. Epub 2010 Dec 22.
Results Reference
background
PubMed Identifier
25010782
Citation
Kocjancic ST, Jazbec A, Noc M. Impact of intensified postresuscitation treatment on outcome of comatose survivors of out-of-hospital cardiac arrest according to initial rhythm. Resuscitation. 2014 Oct;85(10):1364-9. doi: 10.1016/j.resuscitation.2014.06.028. Epub 2014 Jul 8.
Results Reference
background
PubMed Identifier
21816940
Citation
Perbet S, Mongardon N, Dumas F, Bruel C, Lemiale V, Mourvillier B, Carli P, Varenne O, Mira JP, Wolff M, Cariou A. Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med. 2011 Nov 1;184(9):1048-54. doi: 10.1164/rccm.201102-0331OC.
Results Reference
background
PubMed Identifier
21336107
Citation
Mongardon N, Perbet S, Lemiale V, Dumas F, Poupet H, Charpentier J, Pene F, Chiche JD, Mira JP, Cariou A. Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era. Crit Care Med. 2011 Jun;39(6):1359-64. doi: 10.1097/CCM.0b013e3182120b56.
Results Reference
background
PubMed Identifier
14987786
Citation
Gajic O, Festic E, Afessa B. Infectious complications in survivors of cardiac arrest admitted to the medical intensive care unit. Resuscitation. 2004 Jan;60(1):65-9. doi: 10.1016/j.resuscitation.2003.08.005.
Results Reference
background
PubMed Identifier
24268585
Citation
Woo JH, Lim YS, Yang HJ, Park WB, Cho JS, Kim JJ, Hyun SY, Lee G. Factors associated with pneumonia in post-cardiac arrest patients receiving therapeutic hypothermia. Am J Emerg Med. 2014 Feb;32(2):150-5. doi: 10.1016/j.ajem.2013.10.035. Epub 2013 Oct 26.
Results Reference
background
PubMed Identifier
27987397
Citation
Ribaric SF, Turel M, Knafelj R, Gorjup V, Stanic R, Gradisek P, Cerovic O, Mirkovic T, Noc M. Prophylactic versus clinically-driven antibiotics in comatose survivors of out-of-hospital cardiac arrest-A randomized pilot study. Resuscitation. 2017 Feb;111:103-109. doi: 10.1016/j.resuscitation.2016.11.025. Epub 2016 Dec 14.
Results Reference
derived

Learn more about this trial

Prophylactic Antibiotics in Comatose Survivors of Out-of-hospital Cardiac Arrest

We'll reach out to this number within 24 hrs